-
Signature
-
/s/ Brian Sandstrom, as Attorney-in-Fact
-
Stock symbol
-
MRNA
-
Transactions as of
-
Nov 30, 2022
-
Transactions value $
-
-$305,180
-
Form type
-
4
-
Date filed
-
12/2/2022, 03:12 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
MRNA |
Common Stock |
Options Exercise |
$41.9K |
+2K |
+15.62% |
$20.93* |
14.8K |
Nov 30, 2022 |
Direct |
F1 |
transaction |
MRNA |
Common Stock |
Sale |
-$347K |
-2K |
-13.51% |
$173.52 |
12.8K |
Nov 30, 2022 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
MRNA |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2K |
-0.94% |
$0.00 |
211K |
Nov 30, 2022 |
Common Stock |
2K |
$20.93 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Technical Operations and Quality Officer